pyrroles has been researched along with Autoimmune Thyroiditis in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Atzori, F; Baghino, G; Boi, F; Ionta, MT; Mariotti, S; Pani, F; Scartozzi, M; Tanca, L | 1 |
| Alexandrescu, DT; Dasanu, CA; Dawson, N; Farzanmehr, H; Popoveniuc, G; Wartofsky, L | 1 |
| Akarsu, E; Babacan, T; Balakan, O; Sevinc, A | 1 |
| Cía, M; Martínez, M; Otermin, I; Pereda, A; Rivero, M | 1 |
4 other study(ies) available for pyrroles and Autoimmune Thyroiditis
| Article | Year |
|---|---|
Hypothyroidism and Thyroid Autoimmunity as a Prognostic Biomarker of Better Response in Metastatic Cancer Long-Term Survivors Treated with Sunitinib.
Topics: Aged; Antineoplastic Agents; Biomarkers; Female; Humans; Hypothyroidism; Immunoenzyme Techniques; Indoles; Male; Middle Aged; Neoplasm Metastasis; Prognosis; Pyrroles; Sunitinib; Survivors; Thyroid Neoplasms; Thyroiditis, Autoimmune; Treatment Outcome | 2016 |
Sunitinib-associated lymphocytic thyroiditis without circulating antithyroid antibodies.
Topics: Antibodies, Anti-Idiotypic; Antineoplastic Agents; Biopsy, Fine-Needle; Carcinoma, Renal Cell; Dose-Response Relationship, Drug; Humans; Indoles; Kidney Neoplasms; Male; Middle Aged; Pyrroles; Sunitinib; Thyroid Gland; Thyroiditis, Autoimmune; Thyrotropin; Thyroxine; Triiodothyronine | 2008 |
Sunitinib-induced autoimmune thyroiditis in a patient with metastatic renal cell carcinoma: a case report.
Topics: Aged; Antibodies; Carcinoma, Renal Cell; Female; Humans; Indoles; Iodide Peroxidase; Kidney Neoplasms; Pyrroles; Sunitinib; Thyroglobulin; Thyroiditis, Autoimmune; Tomography, X-Ray Computed | 2012 |
[Musculoskeletal adverse effects of levofloxacin].
Topics: Anti-Bacterial Agents; Arthralgia; Arthritis; Arthritis, Infectious; Arthroplasty, Replacement, Knee; Atorvastatin; Combined Modality Therapy; Debridement; Diagnosis, Differential; Doxycycline; Drug Interactions; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Levofloxacin; Middle Aged; Ofloxacin; Postoperative Complications; Prosthesis-Related Infections; Pyrroles; Recurrence; Reoperation; Rifampin; Thyroiditis, Autoimmune; Thyroxine; Trimethoprim, Sulfamethoxazole Drug Combination | 2006 |